Search

Search Constraints

You searched for: Author/Creator Zhou, X

Search Results

44. LBA19Updated overall survival (OS) from extended follow up in ARCHER 1050: A randomized phase III study comparing dacomitinib with gefitinib as first-line therapy for patients (pts) with EGFR mutations. (24th November 2019)